JP2022546590A5 - - Google Patents
Info
- Publication number
- JP2022546590A5 JP2022546590A5 JP2022514665A JP2022514665A JP2022546590A5 JP 2022546590 A5 JP2022546590 A5 JP 2022546590A5 JP 2022514665 A JP2022514665 A JP 2022514665A JP 2022514665 A JP2022514665 A JP 2022514665A JP 2022546590 A5 JP2022546590 A5 JP 2022546590A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- optionally
- seq
- domain
- chimeric polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962897062P | 2019-09-06 | 2019-09-06 | |
| US62/897,062 | 2019-09-06 | ||
| PCT/US2020/049521 WO2021046432A1 (en) | 2019-09-06 | 2020-09-04 | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546590A JP2022546590A (ja) | 2022-11-04 |
| JP2022546590A5 true JP2022546590A5 (https=) | 2023-09-11 |
| JP7820819B2 JP7820819B2 (ja) | 2026-02-26 |
Family
ID=74852083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514665A Active JP7820819B2 (ja) | 2019-09-06 | 2020-09-04 | がんの処置のためのキメラ抗原受容体ならびに関連した方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230049954A1 (https=) |
| EP (1) | EP4025225A4 (https=) |
| JP (1) | JP7820819B2 (https=) |
| KR (1) | KR20220077127A (https=) |
| CN (1) | CN114765980A (https=) |
| AU (1) | AU2020343025A1 (https=) |
| CA (1) | CA3153311A1 (https=) |
| IL (1) | IL291090A (https=) |
| WO (1) | WO2021046432A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0979102A4 (en) * | 1997-04-30 | 2005-11-23 | Enzon Inc | DETAILED POLYPEPTIDE MODIFIED BY POLYALKYLENE OXIDE |
| GB0523954D0 (en) * | 2005-11-24 | 2006-01-04 | Ucb Celltech | Bioassays |
| WO2009086132A2 (en) * | 2007-12-20 | 2009-07-09 | University Of Southern California | Design of spacers to increase the expression of recombinant fusion proteins |
| US7951370B2 (en) * | 2008-03-12 | 2011-05-31 | Imclone Llc | Anti-TYRP1 antibodies |
| EP3202783A1 (en) * | 2016-02-02 | 2017-08-09 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Engineered antigen presenting cells and uses thereof |
| EP3432924A1 (en) | 2016-03-23 | 2019-01-30 | Novartis AG | Cell secreted minibodies and uses thereof |
| WO2018075586A1 (en) * | 2016-10-18 | 2018-04-26 | Memorial Sloan-Kettering Cancer Center | Antigen-binding proteins targeting melanoma differentiation antigens and uses thereof |
| US10415017B2 (en) | 2017-05-17 | 2019-09-17 | Thunder Biotech, Inc. | Transgenic macrophages, chimeric antigen receptors, and associated methods |
| WO2018231759A1 (en) | 2017-06-12 | 2018-12-20 | Obsidian Therapeutics, Inc. | Pde5 compositions and methods for immunotherapy |
| CN119193493A (zh) * | 2017-12-08 | 2024-12-27 | 朱诺治疗学股份有限公司 | 生产工程化t细胞组合物的过程 |
| JP7566628B2 (ja) | 2018-01-10 | 2024-10-15 | ザ ジェネラル ホスピタル コーポレイション | キメラ抗原受容体を発現する免疫細胞 |
| CN112566643A (zh) * | 2018-06-12 | 2021-03-26 | 加利福尼亚大学董事会 | 用于治疗癌症的单链双特异性嵌合抗原受体 |
-
2020
- 2020-09-04 KR KR1020227011318A patent/KR20220077127A/ko not_active Ceased
- 2020-09-04 CA CA3153311A patent/CA3153311A1/en active Pending
- 2020-09-04 US US17/640,281 patent/US20230049954A1/en active Pending
- 2020-09-04 EP EP20859922.5A patent/EP4025225A4/en active Pending
- 2020-09-04 WO PCT/US2020/049521 patent/WO2021046432A1/en not_active Ceased
- 2020-09-04 AU AU2020343025A patent/AU2020343025A1/en active Pending
- 2020-09-04 JP JP2022514665A patent/JP7820819B2/ja active Active
- 2020-09-04 CN CN202080077466.5A patent/CN114765980A/zh active Pending
-
2022
- 2022-03-03 IL IL291090A patent/IL291090A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262321B1 (en) | Compositions and methods for selective protein expression | |
| KR20230011959A (ko) | 동종이계 이식을 위한 조작된 면역 세포 | |
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| CN121779568A (zh) | 与t细胞结合的多功能分子及其治疗自身免疫性病症的用途 | |
| JP2024050549A (ja) | 二重特異性ｔ細胞誘導体及びその使用 | |
| US20240123068A1 (en) | Cd19 binders, car-t constructs comprising the same, and methods of using the same | |
| CA3189677A1 (en) | Chimeric molecules providing targeted costimulation for adoptive cell therapy | |
| US20240000938A1 (en) | Adoptive cell therapy for treatment of cancer associated with loss of heterozygosity | |
| EP3655440A1 (en) | Compositions and methods for targeting cd33-expressing cancers | |
| WO2023160260A1 (zh) | Cd7-car-t细胞及其制备方法和应用 | |
| WO2021072127A2 (en) | Engineered trimeric cd70 proteins and uses thereof | |
| JP2023516067A5 (https=) | ||
| WO2023202280A1 (zh) | 抗B7H6的scFv抗体、其编码基因及其应用 | |
| CN110092836A (zh) | 用于治疗胰腺癌或胆管类癌的嵌合抗原受体 | |
| US20240226154A9 (en) | Car-t constructs comprising a novel cd19 binder combined with il18 and methods of using the same | |
| US20240384293A1 (en) | Viral vector production system | |
| CA3091143A1 (en) | Foxp3 targeting agent compositions and methods of use for adoptive cell therapy | |
| CN115785279A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 | |
| EP4647445A1 (en) | Antigen-binding proteins targeting ror1 | |
| US20220370498A1 (en) | Immune cells expressing receptor specific to class i mhc molecule and interfering rna for hla gene | |
| US20220315931A1 (en) | Immune cells expressing receptor specific to class i mhc molecule and interfering rna for beta2 microglobulin gene | |
| JP2022546590A5 (https=) | ||
| CN117098782A (zh) | 靶向cldn18.2的抗原结合蛋白及其用途 | |
| WO2026047626A1 (en) | Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy |